Skip to main content

Pfizer agrees to buy cancer behemoth Medivation for $14 billion

Pfizer has agreed to buy cancer-drug company Medivation for $14 billion
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.